Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurosense Therapeutics Ltd

1.22
-0.0421-3.34%
Post-market: 1.220.00000.00%17:38 EDT
Volume:245.81K
Turnover:304.26K
Market Cap:29.22M
PE:-2.22
High:1.36
Open:1.34
Low:1.18
Close:1.26
Loading ...
Mar 22, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 14, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Dec 06, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 10, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 10, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 01, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers